Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Sarcoma 2Thoracic 1Breast 1

Conditions

Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 44Radiosurgery 41Early Intervention, Educational 34Standard of Care 32Educational Status 31Exercise 30Methods 29Drug Therapy 26Radiotherapy 23Magnetic Resonance Spectroscopy 23Practice Guidelines as Topic 22Surveys and Questionnaires 21X-Rays 17Pemetrexed 17Carboplatin 16Biopsy 16Tomography, X-Ray Computed 14Thoracic Surgery, Video-Assisted 14Therapeutics 12Interviews as Topic 12Fluorodeoxyglucose F18 12Gefitinib 11Cisplatin 11Specimen Handling 10Patient Navigation 10Cryosurgery 10Anterior Temporal Lobectomy 10anlotinib 9Surgical Procedures, Operative 9Psychiatric Rehabilitation 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Transurethral Resection of Bladder × Thoracic × Clear all
NCT00653250 2013-05-21

Celecoxib in Treating Patients With Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer

Vanderbilt-Ingram Cancer Center

Phase NA Completed
22 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡